U.S. Markets closed

Dara BioSciences announces at-the-market common stock sales program

DARA BioSciences announced that it has entered into an "At-the-Market" Sales Agreement, dated August 19, with BTIG. Pursuant to the agreement the company may sell from time to time, under its effective registration statement on Form S-3, up to $2.73M in aggregate offering price of its common stock, par value $0.01, per share through BTIG, acting as sales agent. The ATM places no restrictions on DARA's ability to enter into and consummate other equity and debt financing transactions.